Hartford Business Journal

wide market share lead in the state, he said one of his top priorities is to advance more value-based contracts with providers that pay doctors and hospitals more based on performance rather than a fee-for-service model. In September Anthem announced a new agreement with Hartford HealthCare that makes a shift toward value-driven healthcare programs by increasing the focus on primary and preventative care. Trevor MacDougall, Alexander Zinke and Paul Sanders Connecticut's biotech industry predominantly resides in New Haven but Greater Hartford also has a few players. One is Rocky Hill-based Lumeda, which is developing a lung can- cer-killing light therapy. $ 9,370 * health plan refund? Now, that's refreshing. It's possible with an Oxford Level Funded health plan — built to help your business get back to business faster. Level funded plans are based only on your plan participants, so if their medical claims are lower than expected, your health plan may get a surplus refund* at year-end. For details and a quote, contact your broker or Oxford representative * Yep, that's a real number. Among the 36% of UnitedHealthcare's level funded business customers nationwide who received a refund, the average refund was $9,370. UnitedHealthcare internal reconciliation analysis, April 1, 2020 through March 31, 2021. Please consult a tax and/or legal advisor to determine if, by receiving this refund, there are any restrictions or obligations. Surplus refund available only where allowed by state law. Administrative services provided by Oxford Health Plans LLC. Stop-loss insurance is underwritten by All Savers Insurance Company in CT, UnitedHealthcare Life Insurance Company in NJ, and UnitedHealthcare Insurance Company of New York in NY. B2B EI21987012.0-OXF 9/21 © 2021 Oxford Health Plans LLC. All Rights Reserved. 21-813504-M POWER 25 HEALTHCARE He formerly was chief operating officer at Catholic Charities for the Archdiocese of Hartford. Lou Gianquinto Lou Gianquinto leads the state's largest health plan. He was named president of An- them Blue Cross and Blue Shield of Connecticut in Nov. 2020, replacing Jill Hummel, a well-respected insur- ance executive who spent seven years in the same role. Leading Anthem's Connecticut business is a bit of a home- coming for Gianquinto. He's got strong ties to the state having graduated from Southern Con- necticut State University and earned an MBA from the University of New Haven. He also held several jobs in the Connecticut insurance industry at companies including UnitedHealth- care and Oxford Health Plans, where he led initiatives to improve quality, manage costs and increase afford- ability. Most recently he served as pres- ident of Missouri Care, Anthem's Medicaid business in Missouri. As he works to protect Anthem's Leading the startup are Trevor MacDougall (co-founder), Alexan- der Zinke (CEO) and Paul Sanders (co-founder). Lumeda's photodynamic therapy technology, which was developed and licensed from oncologists at Buf- falo's Roswell Park Comprehensive Cancer Center, is an optical device that automates the targeting and dosage of laser light to the site of a newly-removed thoracic tumor. That light interacts with a drug called Pho- tofrin that's injected into the patient ahead of surgery and ultimately kills cancerous cells. Improving the health of tissue adja- cent to a tumor is key to reducing the rate of cancer recurrence. The startup has some momentum, having raised $5.3 million as of April. Sanders and MacDougall have a long history together across multiple companies and roles. The two first crossed paths work- ing at 3M in West Haven. In the mid- 1990s, they switched jobs together and went to Wallingford-based CiDRA's optical-sensing division, where they became steeped in mon- itoring technology for oil wells, and first crossed paths with Alan Kersey, a CiDRA executive and entrepreneur who nearly 20 years later would help seed Lumeda as a partner with Branford venture capital firm Cycle Venture Partners. The co-founders brought in Zinke, a veteran of business development and commercialization projects in health care, as CEO. Deborah Weymouth Deborah Weymouth is the CEO of Eastern Connecticut Health Network (ECHN), which operates Man- chester Memo- rial and Rockville General hospitals, a 130-bed skilled nursing facility, and a medical group of over 400 provid- ers. Like all hospital networks, ECHN had to deal with the financial dif- ficulties caused by the pandemic, mainly a drop in elective procedures at the beginning of the outbreak last spring. But ECHN has had a long recent history of financial and other issues, which eventually led it to getting acquired by California-based for-profit Prospect Medical Holdings in 2016. Prospect also owns Water- bury Hospital. That deal has brought a lot of scru- tiny as Connecticut hospitals have traditionally operated as not-for-profit entities. In fiscal 2019, before Weymouth arrived at ECHN, Prospect's Con- necticut operations reported an operating loss of $8.7 million and an Lou Gianquinto Deborah Weymouth The leadership team at Lumeda consists of, left to right, Trevor MacDougall, founder; Alexander Zinke, CEO, and Paul Sanders, founder.

• Cover